ADA and diffuse midline glioma: Treatment with 160 μM cordycepin also increased cleaved PARP protein in low ADA active AT/RT (BT37) and diffuse midline glioma H3 K27-altered cells (JHH-DIPG1), consistent with an increase in apoptosis (Figure 6E).